Zheng, C., Guo, H., Mo, Y., & Liu, G. (2024). Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance. Recent patents on anti-cancer drug discovery, 19(5), 681. https://doi.org/10.2174/1574892819666230831112815
Chicago Style (17th ed.) CitationZheng, Chang, Hanbin Guo, Yongpan Mo, and Guowen Liu. "Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and Their Clinical Prognostic Significance." Recent Patents on Anti-cancer Drug Discovery 19, no. 5 (2024): 681. https://doi.org/10.2174/1574892819666230831112815.
MLA (9th ed.) CitationZheng, Chang, et al. "Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and Their Clinical Prognostic Significance." Recent Patents on Anti-cancer Drug Discovery, vol. 19, no. 5, 2024, p. 681, https://doi.org/10.2174/1574892819666230831112815.